Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-28 Purchase | 2021-06-29 4:16 pm | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 1,088 | $9.01 | $9,803 | 1,088 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-23 Option Award | 2024-09-25 4:55 pm | N/A 2034-09-23 | AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-01-26 Option Award | 2024-01-30 9:00 pm | N/A 2034-01-25 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 4:07 pm | N/A 2033-06-30 | AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 4:16 pm | N/A 2033-04-25 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 127,500 | $0 | 127,500 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-11 4:15 pm | N/A 2032-08-08 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 4:15 pm | N/A 2032-01-18 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-12-17 Ownership | 2022-01-07 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 1,088 | $0 | 1,248 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 4:24 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director | 49,020 | $0 | 49,020 (Direct) | View |
| 2020-12-03 Option Award | 2020-12-07 4:30 pm | N/A 2030-12-02 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 153,600 | $0 | 153,600 (Direct) | View |
Ownership | 2020-12-07 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 0 | $0 | 0 (Direct) | View |